When to treat hyperlipidemia.
Kane
J P
JP
Cardiovascular Research Institute, University of California, San Francisco.
Malloy
M J
MJ
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology; D002784:Cholesterol / Q000378:metabolism; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003084:Colestipol / Q000627:therapeutic use; D015248:Gemfibrozil; D006801:Humans; D006937:Hypercholesterolemia / Q000628:therapy; D006949:Hyperlipidemias / Q000628:therapy*; D009355:Neomycin / Q000627:therapeutic use; D009525:Niacin / Q000627:therapeutic use; D010421:Pentanoic Acids / Q000627:therapeutic use; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
D010421:Pentanoic Acids; D014280:Triglycerides; D002792:Cholestyramine Resin; D009525:Niacin; D002784:Cholesterol; D002994:Clofibrate; D009355:Neomycin; D003084:Colestipol; D015248:Gemfibrozil